NeoStem, Inc. reported that its China subsidiary, Suzhou Erye Pharma, was granted SFDA approval to produce cloxacillin sodium API, a generic anti-infective. Because it is included in China’s National Medical Reimbursement Insurance List, Cloxacillin sodium is eligible for reimbursement by the government's healthcare programs. More details...

Stock Symbol: (NYSE Amex: NBS)